Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Moa Fransson
Person

Moa Fransson

Tracked across 1 events · 6 articles · First seen Aug 19, 2026 · Last active Aug 19, 2026

Sentiment
10
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 10
Business
BioArctic Mesenkia glioblastoma research collaboration
On August 19, 2026, BioArctic and Bicara Therapeutics announced a research collaboration agreement to develop a novel antibody-based treatment for glioblastoma, an aggressive brain cancer. The collaboration combines BioArctic's BrainTransporter technology with Mesenkia's KITAIbodies platform,…
Impact: As CEO of Mesenkia, Moa Fransson announced the collaboration, highlighting its importance for Mesenkia's development.
Aug 19, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Moa Fransson live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.